業績一覧
ACHIEVEMENT LIST
-
Kobayashi K, Hanai N, Yoshimoto S, Saito Y, Homma A: Current topics and management of head and neck sarcomas
Jpn J Clin Oncol. 53(9): 743-756, 2023
-
Takeuchi S, Hirata K, Magota K, Watanabe S, Moku R, Shiiya A, Taguchi J, Ariga S, Goda T, Ohhara Y, Noguchi T, Shimizu Y, Kinoshita I, Honma R, Tsuji Y, Homma A, Dosaka-Akita H: Early prediction of treatment outcome for lenvatinib using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, non-randomised study
EJNMMI Res. 13(1): 69, 2023
-
Fujima N, Nakagawa J, Kameda H, Ikebe Y, Harada T, Shimizu Y, Tsushima N, Kano S, Homma A, Kwon J, Yoneyama M, Kudo K: Improvement of image quality in diffusion-weighted imaging with model-based deep learning reconstruction for evaluations of the head and neck
MAGMA. 37(3): 439-447, 2023
-
Maeda T, Ishikawa K, Oda Y, Kano S, Tsushima N, Sakashita T, Homma A, Yamamoto Y, Funayama E: Utility of Color Doppler Ultrasonography in Monitoring of a Free Jejunal Flap
Laryngoscope. 133(12): 3361-3369, 2023
-
Robbins KT, Ronen O, Saba NF, Strojan P, Vander Poorten V, Mäkitie A, López F, Rodrigo JP, Homma A, Hanna E, Ferlito A: Progress and emerging strategies to preserve function in the treatment of sinonasal cancer
Head Neck 45(11): 2955-2966, 2023
-
Yasuda K, Uchinami Y, Kano S, Taguchi J, Kawakita D, Kitayama M, Nishioka K, Mori T, Koizumi F, Fujii Y, Shimizu Y, Kobashi K, Yoshimoto S, Nibu KI, Homma A, Aoyama H: Radiotherapy with or without chemotherapy for locally advanced head and neck cancer in elderly patients: analysis of the Head and Neck Cancer Registry of Japan
Int J Clin Oncol. 29(3): 241-247, 2023
-
Yokota T, Zenda S, Kodaira T, Kiyota N, Fujimoto Y, Wasano K, Takahashi R, Mizowaki T, Homma A, Sasaki K, Machida R, Sekino Y, Fukuda H, Japan Clinical Oncology Group Radiation Therapy Study Group, Japan Clinical Oncology Group Head and Neck Cancer Study Group: Novel approach of prophylactic radiation to reduce toxicities comparing 2-step40 with 56-Gy simultaneous integrated boost intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the head and neck, an intergroup phase III trial (JCOG1912, NEW BRIDGE)
BMC Cancer. 23(1): 1068, 2023
-
Okano M, Fujieda S, Gotoh M, Kurono Y, Matsubara A, Ohta N, Kamijo A, Yamada T, Nakamaru Y, Asako M, Sakurai D, Terada T, Yonekura S, Sakashita M, Okubo K: Executive summary: Japanese guidelines for allergic rhinitis 2020
Allergol Int. 72(1):41-53, 2023
-
Shimoda H, Teshima M, Murase T, Nagao T, Kusafuka K, Nakaguro M, Urano M, Taguchi KI, Yamamoto H, Kano S, Tada Y, Tsukahara K, Okami K, Onitsuka T, Fujimoto Y, Kawakita D, Sakurai K, Hanai N, Nagao T, Kawata R, Hato N, Nibu KI, Inagaki H: Prognostic scores for patients with salivary adenoid cystic carcinoma without lymph node metastasis
Oral Oncol. 145: 106491, 2023
-
Hirai H, Nakaguro M, Tada Y, Saigusa N, Kawakita D, Honma Y, Kano S, Tsukahara K, Ozawa H, Okada T, Okami K, Yamazaki K, Sato Y, Urano M, Kajiwara M, Utsumi Y, Shimura T, Fushimi C, Shimizu A, Kondo T, Imanishi Y, Sakai A, Sato Y, Togashi T, Hanazawa T, Matsuki T, Yamazaki K, Nagao T: Prognostic value and clinicopathological roles of the tumor immune microenvironment in salivary duct carcinoma
Virchows Arch. 483(3): 367-379, 2023